Books in the Hematologic Malignancies series

The diversity of MDS gives rise to challenges in diagnosis and clinical decision making, and the highly variable clinical course necessitates a risk-adapted treatment strategy and the application of disease-specific therapies.

This book summarizes current knowledge on chronic lymphocytic leukemia (CLL), taking into account the most recent research. General treatment concepts are clearly described, and it is explained how choice of treatment for CLL depends on stage, age, and performance status as well as specific genetic aberrations.